InflaRx cofounder and CEO Niels Riedemann, M.D. shares the overarching pillars that have shaped his career as a physician, ...

Pivotal trial design can make or break a new therapy's commercial viability. This article explores how choosing the right ...

Disease progression in metastatic breast cancer is a challenge that no single entity can solve alone. Breakthroughs in ...

Anne Zimmerman, editor-in-chief of the Columbia University online journal, <a href=" target="_blank">Voices in Bioethics ...

With just the click of a button on your smartphone, you can order virtually anything and have it on your doorstep in one or ...

Then: In 2016, when former Life Science Leader editor Rob Wright wrote about cofounder Peter Hecht and Ironwood Pharmaceuticals, the company was ascending. After its initial launch in 1998, the ...

Globalization presents both opportunities and challenges for the pharmaceutical industry. Companies must navigate diverse regulatory landscapes, ensuring compliance while maintaining product quality.

This presentation highlights key pharmaceutical launches anticipated in 2025, emphasizing their potential to address unmet needs across various medical fields. The document covers new developments in ...

Disagreements about budgets can delay or stall drug development. As the clinical research industry experiences unprecedented rises in costs, having the most current data available when creating and ...